Insights
Insights From Our Experts
Articles
Optimizing Specialty Pharmacy Networks: A Best-in-Class Approach for Rare Disease Therapies
For manufacturers of rare disease therapies, selecting the right specialty pharmacy model is a crucial decision that directly impacts patient access, adherence and overall brand success. An exclusive specialty pharmacy model offers distinct advantages, including streamlined…
Overcoming the Odds: How EVERSANA Helped a Family Navigate Their Rare Disease Journey
A Rare Diagnosis and the Start of a Family’s Courageous Journey For families navigating the complexities of a rare disease diagnosis, the path can be filled with uncertainty, challenges and moments of profound resilience. One such…
Rare Disease Care in India: A Path to Positive Impact
India’s rare disease market is on the rise, expected to grow from $2.74 billion to $6.6 billion by 2030. However, challenges such as delayed diagnoses, limited treatment accessibility and underutilized government funds continue to impact patient…
Successfully Navigating the Complexity of Market Access Across Europe to Improve Health Equity
Navigating the complexities of bringing new drug therapies to market in Europe is a formidable challenge, especially with the diverse and fragmented reimbursement landscape across the EU’s 27 member states. In this insightful article published in…
New Models of Benefits Verification Solve for Complexity, Accelerate Speed to Therapy and Deliver Price Transparency
Navigating health care insurance coverage can be a supremely convoluted process for anyone, especially patients or caregivers recently faced with coping with a life-threatening disease. While the advancement of many new treatments and scientific innovations in…
Unlocking the Power of Data, Artificial Intelligence and Digital Innovations to Revolutionize Care for Rare Disease Patients
Posted by Maria Kirsch , Scott Snyder , Faruk Capan , Pierantonio Russo, MD, FCPP, FAAP, STS on July 20, 20237/20/23
Rare diseases and developing and distributing the therapies that treat them create highly complex challenges for pharmaceutical manufacturers, and certainly for the patients and providers impacted by them every day. Because these diseases are often extremely…
Digital Guide to Commercializing Complex Therapeutics
Pharmaceutical manufacturers specializing in Rare Disease, Oncology, Personalized Cancer Immunotherapy, and Cell and Gene therapies encounter a range of complex challenges, including advancements in medicine and technology, changing patient and provider needs, market access, regulatory pathways,…
Unlocking Success: Exploring Critical Factors for Launching Orphan Drugs
A Conversation with Ashley Cox, Senior Principal, Head of Europe, EVERSANA MANAGEMENT CONSULTING, and Sid Agrawal, Senior Principal, EVERSANA MANAGEMENT CONSULTING Join Ashley Cox, Senior Principal and Head of Europe, and Sid Agrawal, Senior Principal, as…
Patient-centric Approach to Clinical Trial Support Leveraging Medical Information Services
The number of clinical studies conducted has steadily shown a significant increase year over year for the past two decades. However, the number of new drug and biologic approvals have not seen this same kind of…
Improving the Patient Experience with Digital Tools
EVERSANA’s Patient Services expert, Skyler Vise, Senior Director, Client & Delivery Excellence, EVERSANA, and Ida Goldstein, Senior Director, Trade, Distribution, and Patient Services, Mirum Pharmaceutical, presented at Access USA covering how digital tools can improve the…